Related Experiment Video
Updated: Jun 18, 2025

Stereotactic Injection of MicroRNA-expressing Lentiviruses to the Mouse Hippocampus CA1 Region and Assessment of the Behavioral Outcome
Published on: June 10, 2013
miR-143-3p modulates depressive-like behaviors via Lasp1 in the mouse ventral hippocampus
Hui Yu1, Xiaobing Li2,3, Qiyao Zhang2
1Department of Cell Biology, Shandong Provincial Key Laboratory of Mental Disorders, School of Basic Medical Sciences, Shandong University, 250012, Jinan, Shandong, China.
Abstract:
Depression is a prevalent and intricate mental disorder. The involvement of small RNA molecules, such as microRNAs in the pathogenesis and neuronal mechanisms underlying the depression have been documented. Previous studies have demonstrated the involvement of microRNA-143-3p (miR-143-3p) in the process of fear memory and pathogenesis of ischemia; however, the relationship between miR-143-3p and depression remains poorly understood. Here we utilized two kinds of mouse models to investigate the role of miR-143-3p in the pathogenesis of depression. Our findings reveal that the expression of miR-143-3p is upregulated in the ventral hippocampus (VH) of mice subjected to chronic restraint stress (CRS) or acute Lipopolysaccharide (LPS) treatment. Inhibiting the expression of miR-143-3p in the VH effectively alleviates depressive-like behaviors in CRS and LPS-treated mice. Furthermore, we identify Lasp1 as one of the downstream target genes regulated by miR-143-3p. The miR-143-3p/Lasp1 axis primarily affects the occurrence of depressive-like behaviors in mice by modulating synapse numbers in the VH. Finally, miR-143-3p/Lasp1-induced F-actin change is responsible for the synaptic number variations in the VH. In conclusion, this study enhances our understanding of microRNA-mediated depression pathogenesis and provides novel prospects for developing therapeutic approaches for this intractable mood disorder.
Insights
This study reveals that microRNA-143-3p (miR-143-3p) is upregulated in depression models. Inhibiting miR-143-3p in the ventral hippocampus alleviates depressive behaviors by modulating synapse numbers.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Depression is a complex mental disorder with poorly understood mechanisms.
- MicroRNAs, including microRNA-143-3p (miR-143-3p), are implicated in neuronal function and disease pathogenesis.
- The specific role of miR-143-3p in depression remains largely unexplored.
Purpose of the Study:
- To investigate the role of miR-143-3p in the pathogenesis of depression.
- To explore the therapeutic potential of targeting miR-143-3p in depression.
Main Methods:
- Utilized chronic restraint stress (CRS) and acute lipopolysaccharide (LPS) mouse models of depression.
- Measured miR-143-3p expression in the ventral hippocampus (VH).
- Inhibited miR-143-3p in the VH and assessed depressive-like behaviors, identifying downstream targets and molecular pathways.
Main Results:
- miR-143-3p expression was significantly upregulated in the VH of mice under CRS and LPS treatment.
- Inhibition of miR-143-3p in the VH ameliorated depressive-like behaviors in both models.
- Lasp1 was identified as a downstream target of miR-143-3p, with the miR-143-3p/Lasp1 axis modulating synapse numbers in the VH via F-actin changes.
Conclusions:
- miR-143-3p plays a crucial role in the pathogenesis of depression.
- The miR-143-3p/Lasp1 pathway influences depressive behaviors by altering synaptic plasticity in the ventral hippocampus.
- Targeting miR-143-3p offers a potential therapeutic strategy for depression.

